Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-blind, Multi-center Clinical Study Evaluating the Use of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds.

NCT03540004 is registered in ClinicalTrials.gov with MolecuLight Inc. as lead sponsor.

NCT NCT03540004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03540004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-blind, Multi-center Clinical Study Evaluating the Use of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds.
Lead sponsor
MolecuLight Inc.
Phase
Observational
Overall status
Unknown status
Start date
May 23, 2018
Completion date
December 30, 2020
Enrollment
367 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

wound